Augmentin Does NOT Cover Infectious Gastroenteritis and Should Not Be Used
Augmentin (amoxicillin-clavulanate) is not indicated for infectious gastroenteritis and should be avoided in most cases. The 2017 IDSA guidelines explicitly state that empiric antimicrobial therapy is not recommended for acute watery diarrhea, and antibiotics provide no benefit—and may cause harm—in common bacterial gastroenteritis 1.
Why Antibiotics Are Not Recommended
Most Gastroenteritis Is Self-Limited
The vast majority of infectious diarrhea episodes resolve without treatment. The IDSA guidelines emphasize that in most cases, the risks of antibiotic treatment outweigh the benefits 1.
Specific Pathogens Where Antibiotics Cause Harm
Salmonella gastroenteritis: Research demonstrates that amoxicillin provides no clinical benefit and substantially increases bacteriologic relapse (53% vs 0% in placebo) and symptomatic recurrence 2. Antibiotics are explicitly not recommended for uncomplicated Salmonella diarrhea 1.
STEC (Shiga toxin-producing E. coli): β-lactam antibiotics like Augmentin should be avoided due to evidence of harm. Treatment with β-lactams, fluoroquinolones, TMP-SMX, and metronidazole is associated with increased risk of hemolytic uremic syndrome 1.
Clostridioides difficile: Concomitant antibiotic use (including Augmentin) is associated with decreased cure rates and higher relapse rates in CDI 1.
Limited Benefit in Campylobacter
While macrolides or fluoroquinolones show modest benefit (reducing illness by ~1 day) in Campylobacter gastroenteritis, Augmentin is not a recommended agent for this pathogen 1. Treatment is only reasonable for severe/prolonged disease or immunocompromised patients.
When Empiric Antibiotics May Be Considered
The IDSA guidelines specify narrow exceptions 1:
- Immunocompromised patients with acute watery diarrhea
- Ill-appearing young infants with acute watery diarrhea
- NOT for patients with persistent watery diarrhea ≥14 days (empiric treatment should be avoided)
Even in these exceptions, Augmentin is not the preferred agent. If treatment is warranted, fluoroquinolones or macrolides are more appropriate choices based on local resistance patterns.
Augmentin's Actual Indications
The FDA label for Augmentin lists approved indications as acute otitis media, sinusitis, lower respiratory tract infections, skin infections, and urinary tract infections 3—not gastroenteritis. The WHO guidelines recommend amoxicillin-clavulanate for intra-abdominal infections (peritonitis, abscesses), not simple gastroenteritis 4.
Critical Pitfalls to Avoid
- Do not prescribe Augmentin for bloody diarrhea without ruling out STEC—β-lactams may worsen outcomes
- Do not treat uncomplicated Salmonella with any antibiotic—it prolongs carriage and increases relapse
- Avoid empiric antibiotics in travelers' diarrhea unless severe inflammatory diarrhea with fever—and even then, fluoroquinolones or azithromycin are preferred, not Augmentin
- Recognize that antibiotic-associated diarrhea is a common side effect of Augmentin itself (12.9% in pediatric studies) 3
Bottom Line
Augmentin has no role in treating infectious gastroenteritis. The evidence shows either no benefit or actual harm for the common bacterial causes of gastroenteritis. Reserve antibiotics for the rare severe cases in high-risk patients, and when needed, use guideline-recommended agents (fluoroquinolones or macrolides), not Augmentin.